| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.8 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.0099 | 0.9 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |